WallStSmart

GE HealthCare Technologies Inc. (GEHC)vsIntelligent Bio Solutions Inc. (INBS)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

GE HealthCare Technologies Inc. generates 504407% more annual revenue ($21.27B vs $4.22M). GEHC leads profitability with a 9.3% profit margin vs -294.9%. GEHC earns a higher WallStSmart Score of 65/100 (C+).

GEHC

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 6.5Value: 5.7Quality: 4.5
Piotroski: 2/9Altman Z: 1.34

INBS

Avoid

31

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 4.0Quality: 5.0
Piotroski: 4/9Altman Z: -11.18
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for GEHC.

INBSSignificantly Overvalued (-22.9%)

Margin of Safety

-22.9%

Fair Value

$4.27

Current Price

$1.76

$2.51 premium

UndervaluedFair: $4.27Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEHC1 strengths · Avg: 8.0/10
P/E RatioValuation
16.3x8/10

Attractively priced relative to earnings

INBS2 strengths · Avg: 10.0/10
Price/BookValuation
0.9x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
35.8%10/10

Revenue surging 35.8% year-over-year

Areas to Watch

GEHC4 concerns · Avg: 2.8/10
PEG RatioValuation
1.774/10

Expensive relative to growth rate

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Free Cash FlowQuality
$-617.00M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
1.342/10

Distress zone — elevated risk

INBS4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$5.27M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-170.2%2/10

ROE of -170.2% — below average capital efficiency

Free Cash FlowQuality
$-3.18M2/10

Negative free cash flow — burning cash

Comparative Analysis Report

WallStSmart Research

Bull Case : GEHC

The strongest argument for GEHC centers on P/E Ratio.

Bull Case : INBS

The strongest argument for INBS centers on Price/Book, Revenue Growth. Revenue growth of 35.8% demonstrates continued momentum.

Bear Case : GEHC

The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, Free Cash Flow.

Bear Case : INBS

The primary concerns for INBS are EPS Growth, Market Cap, Return on Equity.

Key Dynamics to Monitor

GEHC profiles as a value stock while INBS is a hypergrowth play — different risk/reward profiles.

INBS carries more volatility with a beta of 4.30 — expect wider price swings.

INBS is growing revenue faster at 35.8% — sustainability is the question.

INBS generates stronger free cash flow (-3M), providing more financial flexibility.

Bottom Line

GEHC scores higher overall (65/100 vs 31/100). Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

GE HealthCare Technologies Inc.

HEALTHCARE · MEDICAL DEVICES · USA

GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.

Intelligent Bio Solutions Inc.

HEALTHCARE · MEDICAL DEVICES · USA

Intelligent Bio Solutions Inc. (INBS) is a pioneering biotechnology company focused on delivering cutting-edge diagnostic solutions and biomarker-driven technologies, specifically designed for drug abuse testing and monitoring. Utilizing advanced scientific methodologies, INBS offers rapid and precise testing options that enhance clinical decision-making processes and improve patient outcomes. In a healthcare landscape increasingly reliant on innovative diagnostic tools, INBS is well-positioned to make substantial contributions to this evolving field, reinforcing its dedication to advancing healthcare quality and operational effectiveness.

Want to dig deeper into these stocks?